Welcome to our dedicated page for Northrop Grumman SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Northrop Grumman Corporation (NOC) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Northrop Grumman is a global aerospace and defense technology company, and its filings provide structured insight into its financial performance, capital structure, governance, and key agreements.
Recent Form 8-K filings illustrate the types of information investors can expect. A July 22, 2025 Form 8-K reports that Northrop Grumman issued an earnings release for the quarter ended June 30, 2025, while an October 21, 2025 Form 8-K notes the release of financial results for the quarter ended September 30, 2025. These current reports reference earnings releases furnished as exhibits, which complement the company’s quarterly reports on Form 10-Q and annual reports on Form 10-K that are also accessible through EDGAR.
Another Form 8-K dated September 2, 2025 describes a material definitive agreement: a five-year senior unsecured revolving credit facility intended to support the company’s commercial paper program and other general corporate purposes. The filing outlines key covenants, including a maximum consolidated debt-to-capitalization ratio and customary events of default. A November 6, 2025 Form 8-K details a chief financial officer transition and related compensation decisions approved by the Compensation and Human Capital Committee.
On this page, Stock Titan surfaces such filings in real time and applies AI-powered summaries to explain the significance of documents like 10-K annual reports, 10-Q quarterly reports, and 8-K current reports. Users can also review disclosures related to material agreements and leadership changes, and locate information that may be relevant to insider transactions reported on Form 4. The goal is to make Northrop Grumman’s regulatory record easier to navigate by highlighting key sections and translating technical language into more accessible explanations.
Northrop Grumman executive Robert J. Fleming reported equity award activity involving restricted stock rights and common shares. On 2/17/26, 264 Restricted Stock Rights were exercised, issuing 264 shares of common stock at a stated price of
Following these transactions, Fleming directly held 2,619.03 shares of Northrop Grumman common stock. He also held 6,513 Restricted Stock Rights, which include grants under the company’s long-term incentive plans scheduled to vest on future dates.
Northrop Grumman corporate vice president, controller and chief accounting officer Michael A. Hardesty reported multiple share transactions on February 17, 2026. He acquired 538 Restricted Stock Rights that converted into 538 common shares at no cost upon vesting, then disposed of 243 shares to cover taxes and sold 715.94 shares in an open-market transaction at $700.63 per share, leaving him with 2,672.29 common shares directly owned. Footnotes note these shares vested from awards granted under the company’s long-term incentive stock plans and that additional Restricted Stock Rights remain scheduled to vest in later years.
Northrop Grumman executive Thomas H. Jones, CVP & President Aeronautics Systems, reported equity award activity tied to long-term incentives. On February 17, 2026, 2,152 Restricted Stock Rights (RSRs) vested and converted into an equivalent number of common shares at no exercise price under prior awards.
In connection with this vesting, 1,005 common shares were disposed of at $701.12 per share to cover tax obligations through share withholding, rather than an open-market sale. After these transactions, Jones directly held 11,204.715 common shares, plus 6,513 RSRs scheduled to vest between 2027 and 2029 under the company’s long-term incentive plans.
Northrop Grumman Chair, CEO and President Kathy J. Warden exercised 10,760 Restricted Stock Rights, receiving the same number of common shares at a stated price of $0.00 per share upon vesting on February 17, 2026. To cover tax obligations, 4,857 common shares were disposed of at $701.12 per share through a tax-withholding transaction, leaving her with 196,680.56 directly owned common shares after these transactions. The Restricted Stock Rights and shares were granted under the company’s long-term incentive stock plans and vest on specified future dates.
Northrop Grumman corporate VP and general counsel Kathryn G. Simpson reported several equity transactions in company stock. On February 17, 2026 she exercised 387 Restricted Stock Rights, receiving 387 common shares at a stated price of $0 per share. Of these, 193 shares were disposed of at $701.12 per share to cover tax obligations, and 779 shares were sold in an open-market transaction at $702.56 per share under a Rule 10b5-1 trading plan adopted on February 28, 2025. After these transactions, she directly held 1,068.39 common shares.
Northrop Grumman executive Roshan S. Roeder, CVP & President of Mission Systems, reported a mix of equity award exercises and share disposals. On February 17, 2026, she exercised 2,017 Restricted Stock Rights, receiving an equal number of common shares at a stated price of $0.00 per share.
To cover tax obligations, 992 common shares were disposed of at
Northrop Grumman-related reporting person Michael A. Hardesty reported sales of company common stock. The filing lists proposed sales of
NOC filer submitted a Rule 144 notice to sell 512 shares of common stock. The filing lists the 512 shares as Restricted Stock Vesting from
It also discloses prior sales by Roshan Roeder of 84 shares on
NOC reported a Form 144 filing showing a sale of securities by an insider. The filing shows 779 shares of common stock sold on
NOC submitted a Form 144 indicating an intent to sell restricted common stock under Rule 144. The filing lists multiple vested lots: 4, 53, 188, 1, and 1,944 shares with vesting dates between